A pharmacoeconomic analysis to compare cost-effectiveness of metformin plus teneligliptin with metformin plus glimepiride in patients of type-2 diabetes mellitus

A pharmacoeconomic analysis to compare cost-effectiveness of metformin plus teneligliptin with metformin plus glimepiride in patients of type-2 diabetes mellitus

Background: With the available evidence of early combined oral drug therapies being more effective in lowering blood glucose levels than maximal doses of a single drug, many clinicians are taking the aggressive approach of adding a sulfonylurea or a dipeptidyl peptidase-4 (DPP-4) inhibitor to metfor...

Full description

Bibliographic Details
Main Authors: Tanya Tandon, Ashok K Dubey, Saurabh Srivastava, Sachin Manocha, Ekta Arora, Nazer Hasan
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2019-01-01
Series:Journal of Family Medicine and Primary Care
Subjects:
Cost-effectiveness
glimepiride
teneligliptin
Online Access:http://www.jfmpc.com/article.asp?issn=2249-4863;year=2019;volume=8;issue=3;spage=955;epage=959;aulast=Tandon

Internet

http://www.jfmpc.com/article.asp?issn=2249-4863;year=2019;volume=8;issue=3;spage=955;epage=959;aulast=Tandon

Similar Items